Alto Neuroscience (ANRO) Non-Current Assets (2023 - 2026)

Alto Neuroscience (ANRO) has 4 years of Non-Current Assets data on file, last reported at $7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 15.0% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $29.7 million (up 11.52% YoY), and the FY2025 full-year result was $7.0 million, down 15.04% from the prior year.
• Non-Current Assets rose to $7.1 million in Q1 2026, from $7.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $8.4 million in Q1 2025 to a low of $1.2 million in Q4 2023.
• A 4-year average of $5.9 million and a median of $7.3 million in 2025 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 563.3% in 2024 and retreated 15.04% in 2025, its largest moves.
• Tracing ANRO's Non-Current Assets over 4 years: stood at $1.2 million in 2023, then surged by 563.3% to $8.2 million in 2024, then dropped by 15.04% to $7.0 million in 2025, then rose by 2.32% to $7.1 million in 2026.
• Business Quant data shows ANRO's Non-Current Assets at $7.1 million in Q1 2026, $7.0 million in Q4 2025, and $7.6 million in Q3 2025.